Preview Mode Links will not work in preview mode

Mar 20, 2019

CEO Kevin Conroy shares insights on how Exact Sciences became a leader in the early detection of cancer, helping screen more than 2 million people for colorectal cancer with their non-invasive stool DNA test, Cologuard. Now more than 2,000 employees strong, the company relaunched in Wisconsin in 2009 during a recession and at a time when the state was falling behind on funding and supporting entrepreneurship. Conroy will lead a discussion and take questions on what business leaders in Wisconsin can do to support economic growth and what needs to change to create more success stories.